Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

BACKGROUND: IGF-1 plays a role in the growth of multiple tumor types, including pancreatic cancer. IGF-1 also serves as a growth factor for muscle. The impact of therapeutic targeting of IGF-1 on muscle mass is unknown. METHODS: We evaluated muscle mass at L3 in patients enrolled in a randomized pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogelman, David R., Holmes, Holly, Mohammed, Khalil, Katz, Matthew H. G., Prado, Carla M., Lieffers, Jessica, Garg, Naveen, Varadhachary, Gauri R., Shroff, Rachna, Overman, Michael J., Garrett, Christopher, Wolff, Robert A., Javle, Milind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248412/
https://www.ncbi.nlm.nih.gov/pubmed/24740741
http://dx.doi.org/10.1007/s13539-014-0145-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248412/
https://www.ncbi.nlm.nih.gov/pubmed/24740741
http://dx.doi.org/10.1007/s13539-014-0145-y

Ejemplares similares